| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95% CI for OR | p | OR | 95% CI for OR | p | |
TG: increase (n = 1151) vs not increase (n = 783) | ||||||
 Age | ||||||
  ≤ 40 | 1 |  |  |  |  |  |
  40–50 | 1.067 | 0.825–1.381 | 0.622 |  |  |  |
  > 50 | 0.712 | 0.548–0.926 | 0.011 |  |  |  |
 Premenopause | ||||||
  Pre- | 1 |  |  |  |  |  |
  Post- | 0.671 | 0.557–0.808 | < 0.001 |  |  |  |
 ER | ||||||
  ER− | 1 |  |  |  |  |  |
  ER+ | 1.570 | 1.293–1.905 | < 0.001 |  |  |  |
 PR | ||||||
  PR− | 1 |  |  | 1 |  |  |
  PR+ | 1.656 | 1.371–2.000 | < 0.001 | 1.411 | 1.046–1.904 | 0.024 |
 Preoperative hyperlipidemia | 2.212 | 1.838–2.663 | < 0.001 | 2.121 | 1.745–2.578 | < 0.001 |
TC: increase (n = 785) vs no increase (n = 1149) | ||||||
 Premenopause | ||||||
  Pre- | 1 |  |  |  |  |  |
  Post- | 0.801 | 0.664–0.966 | 0.02 |  |  |  |
 ER | ||||||
  ER− | 1 |  |  |  |  |  |
  ER+ | 1.253 | 1.029–1.526 | 0.025 |  |  |  |
 PR | ||||||
  PR− | 1 |  |  | 1 |  |  |
  PR+ | 1.409 | 1.163–1.707 | < 0.001 | 1.479 | 1.093–2.003 | 0.011 |
 Preoperative hyperlipidemia | 1.710 | 1.419–2.061 | < 0.001 | 1.672 | 1.376–2.030 | < 0.001 |
LDL: increase (n = 1009) vs not increase (n = 925) | ||||||
 Premenopause | ||||||
  Pre- | 1 |  |  |  |  |  |
  Post- | 0.813 | 0.676–0.976 | 0.027 |  |  |  |
 ER | ||||||
  ER− | 1 |  |  |  |  |  |
  ER+ | 1.349 | 1.112–1.635 | 0.002 |  |  |  |
 PR | ||||||
  PR− | 1 |  |  | 1 |  |  |
  PR+ | 1.443 | 1.196–1.740 | < 0.001 | 1.407 | 1.164–1.701 | < 0.001 |
 Preoperative hyperlipidemia | 1.863 | 1.552–2.237 | < 0.001 | 1.838 | 1.530–2.209 | < 0.001 |